Tanaken
Tanaken (1450.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Tanaken (1450.T), featuring income statements, balance sheets, and cash flow data.
Tanaken (1450.T) Income Statement & Financial Overview
Explore comprehensive income reports for Tanaken 1450.T, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.51B | $3.14B | $3.05B | $2.58B |
Cost of Revenue | $2.62B | $2.27B | $2.23B | $1.88B |
Gross Profit | $882.13M | $865.00M | $820.00M | $706.00M |
Gross Profit Ratio | $0.25 | $0.28 | $0.27 | $0.27 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $313.95M | $230.00M | $213.00M | $224.00M |
Operating Expenses | $313.95M | $230.00M | $213.00M | $224.00M |
Total Costs & Expenses | $2.94B | $2.50B | $2.45B | $2.10B |
Interest Income | $33000.00 | $4.82M | $3.21M | $2.00M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $13.49M | $13.00M | $12.64M | $12.30M |
EBITDA | $583.62M | $654.19M | $623.95M | $495.00M |
EBITDA Ratio | $0.17 | $0.21 | $0.20 | $0.19 |
Operating Income | $568.18M | $635.00M | $607.00M | $482.00M |
Operating Income Ratio | $0.16 | $0.20 | $0.20 | $0.19 |
Other Income/Expenses (Net) | $36.12M | $6.00M | $5.00M | -$3.00M |
Income Before Tax | $604.30M | $641.00M | $612.00M | $479.00M |
Income Before Tax Ratio | $0.17 | $0.20 | $0.20 | $0.19 |
Income Tax Expense | $108.24M | $242.00M | $230.00M | $180.00M |
Net Income | $496.06M | $399.00M | $382.00M | $299.00M |
Net Income Ratio | $0.14 | $0.13 | $0.13 | $0.12 |
EPS | $57.03 | $45.87 | $43.84 | $34.47 |
Diluted EPS | $57.03 | $45.87 | $43.84 | $34.47 |
Weighted Avg Shares Outstanding | $8.70M | $8.70M | $8.70M | $8.70M |
Weighted Avg Shares Outstanding (Diluted) | $8.70M | $8.70M | $8.70M | $8.70M |
Over the last four quarters, Tanaken's revenue moved from $2.58B in Q1 2024 to $3.51B in Q4 2024. Operating income in Q4 2024 was $568.18M, with a strong operating margin of 16%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Tanaken remained robust at $583.62M, reflecting operational efficiency. Net income rose to $496.06M, with an EPS of $57.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan